TrialFrontiers in neurology2025
A multicenter, international, randomized, single-blind, placebo-controlled study of the efficacy and safety of inosine-nicotinamide-riboflavin-succinic acid in the acute period of traumatic brain injury in adults.
Tatiana Kharitonova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.